If You Are Caring for An Older Adult with Colorectal Cancer, Please Don’t Skip Your Dental Appointment At Fight CRC, we discuss caregiving often within our resources and also in our conversations with the community. We address the challenges, how to get support, how to…
Read Full Post
American Society of Clinical Oncology’s Gastrointestinal Cancer Symposium (GIASCO) 2019: How you can stay up-to-date on the research from home It seems like just yesterday that the Fight Colorectal Cancer (Fight CRC) team was preparing for the 2018 American Society of Clinical Oncology’s Gastrointestinal Cancer…
Read Full Post
We took the time to break down some basics about rectal cancer surgery. Dr. Jonathan Mitchem of the University of Missouri provided some expert tips and advice to help you prepare for surgery and recovery. The Basics: Types of Rectal Cancer Surgery If you have…
Read Full Post
2018: Fight CRC Patient Education and Research Year in Review This year brought exciting updates, new funding opportunities, additional resources, and exciting advocacy panels. We have no plans of slowing down in 2019! As the year comes to an end, we spent time reflecting on…
Read Full Post
We know you have been hearing a lot lately about the recent lawsuit involving the Affordable Care Act (ACA). There is a lot of information out there so we thought we’d break it down into the most important things you need to know. What is…
Read Full Post
Real Housewives of Atlanta’s Gregg Leakes Decides Against Chemotherapy after Surgery for Colorectal Cancer Are you a Real Housewives fan? If so, you probably know that the show has recently brought colorectal cancer to the spotlight … again. If not, we’ll catch you up quickly….
Read Full Post
What You Should Know about Adoptive Cell Therapy (ACT): Part 1 Read time: 4 minutes What are ACT therapies? Research that has been done on ACT therapies before ACT therapies for colorectal cancer (CRC) This is part one of a two-part series understanding Adoptive Cell…
Read Full Post
FDA Approves Larotrectinib for Advanced Cancers that Expresses TRK Precision medicine took the spotlight again last week as the Federal Drug Administration (FDA) approved the drug larotrectinib (Vitrakvi(r)) developed by Bayer and Loxo Oncology. According to the FDA, larotrectinib is approved for adults (pill form)…
Read Full PostWith the holidays amongst us, it’s a great time to discuss all things family health history. While you’re sitting around the table gobbling down turkey, or snuggling by the fire wrapping presents, it’s important to understand your family history, and if you may be at…
Read Full Post
I joined Fight CRC in October 2018. Prior to that, I worked for Central Care Cancer Center as the Marketing Manager for their Missouri location. I also have over eight years of marketing and event planning experience through past experiences in Minor League Baseball and…
Read Full Post